Highlights
NASDAQ: ALXN       Alexion Pharm Inc
Last Price Today's Change   Day's Range   Trading Volume
168.44   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):2,206,884
4 Weeks Range:151.14 - 168.515
4 Weeks Price Volatility (%):
99.96%
52 Weeks Range:94.82 - 168.515
52 Weeks Price Volatility (%):
99.96%
Average Price Target: 208.00
Price Target Upside/Downside: +39.56

Headlines



No recent Headlines for this stock.


Business Background

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company's products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical development programs include Soliris (eculizumab), cPMP (ALXN1101), SBC-103, ALXN1210 (IV) and ALXN1210 (Subcutaneous). Its Soliris is the therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH) or hemolytic uremic syndrome (aHUS). PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system. Its Strensiq is for the treatment of patients with Hypophosphatasia (HPP). Its product, Kanuma is for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). It is a recombinant form of the human LAL enzyme, which is a replacement therapy that is approved for the treatment for patients with LAL-D.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

10437 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 KSMT 9.900.00 
 HIPS 14.920.00 
 HONE 14.660.00 
 ENZL 64.120.00 
 KOD 117.480.00 
 UPRO 104.180.00 
 COLD 39.160.00 
 ALYA 2.150.00 
 CIGI 103.060.00 
 AXNX 61.950.00 

TOP ARTICLES

1. CryptoNews of the Week CryptoNews
2. Equities Dipped Further on Virus Resurgence State of The Markets
3. Daily Futures Trading Strategy 22 April 2021 Where Futures Lies
4. Bulls Took A Breather Amid Profit Taking State of The Markets
5. Wall Street Breakfast: Coming Of Age? Wall Street Breakfast